Moreover, PPARγ stimulation has a beneficial role in MS [69,70] through the decrease of neuroinflammation [71] and the downregulation of the WNT/β-catenin pathway in MS [17,18]. The gene discussed is PPARG; the disease is myeloid sarcoma.